logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Search
    FiltersReset Filters
    10 results

    • idhifa

      (enasidenib mesylate)
      Medication Details
      Celgene Corporation
      Usage: IDHIFA is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation, confirmed by an FDA-approved test.
      Medication Details
      Drug Interactions

    • inrebic - fedratinib hydrochloride capsule

      (Fedratinib Hydrochloride)
      Medication Details
      Celgene Corporation
      Medication Details
      Drug Interactions

    • istodax - romidepsin

      (Romidepsin)
      Medication Details
      Celgene Corporation
      Medication Details

    • onureg

      (azacitidine)
      Medication Details
      Celgene Corporation
      Usage: ONUREG is indicated for the continued treatment of adults with acute myeloid leukemia who have achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) after intensive induction chemotherapy and are unable to complete intensive curative therapy.
      Medication Details
      Drug Interactions

    • pomalyst

      (pomalidomide)
      Medication Details
      Celgene Corporation
      Usage: POMALYST is indicated for adult patients with multiple myeloma who have received at least two prior therapies and show disease progression, as well as for treating AIDS-related and non-AIDS-related Kaposi sarcoma in adults following failure of other therapies.
      Medication Details
      Drug Interactions

    • reblozyl - luspatercept injection, powder, lyophilized, for solution

      (Luspatercept)
      Medication Details
      Celgene Corporation
      Medication Details

    • revlimid

      (Lenalidomide)
      Medication Details
      Celgene Corporation
      Usage: REVLIMID is indicated for adult patients with multiple myeloma (MM), myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), follicular lymphoma (FL), and marginal zone lymphoma (MZL). It is used in combination with dexamethasone, rituximab products, or as maintenance therapy post-transplant. Not recommended for chronic lymphocytic leukemia (CLL).
      Medication Details
      Drug Interactions

    • thalomid - thalidomide capsule

      (Thalidomide)
      Medication Details
      Celgene Corporation
      Medication Details

    • vidaza - azacitidine injection, powder, lyophilized, for solution

      (Azacitidine)
      Medication Details
      Celgene Corporation
      Medication Details

    • zeposia

      (ozanimod hydrochloride)
      Medication Details
      Celgene Corporation
      Usage: ZEPOSIA is indicated for the treatment of relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) and moderately to severely active ulcerative colitis in adults.
      Medication Details
      Drug Interactions